WebMar 1, 2024 · The COVIMARK is under the trademark classification: Pharmaceutical Products; The COVIMARK trademark covers COVID-19 lateral flow viral antigen … WebMar 1, 2024 · COVIMARK is a trademark and brand of Sorrento Therapeutics, Inc., San Diego , CA . This trademark was filed to USPTO on Wednesday, February 23, 2024. The COVIMARK is under the trademark classification: Pharmaceutical Products; The COVIMARK trademark covers COVID-19 lateral flow viral antigen diagnostic test; …
Sorrento Announces FDA Authorization to Proceed With Phase 1 …
WebSorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focused on delivering innovative and clinically meaningful therapies to address unmet … WebCoviMARK Discussion The website has been up and active. The only way to get the share price up in the short term is have revenue coming in from a US approval. Sorrento has sold 1 million texts in 6 months amounting to $3.1 million. They should be making that in a day!! shortest map route
SORRENTO THERAPEUTICS, INC. : Shareholders Board …
WebInnerScope Hearing Technologies (OTC: INND) Launches HearingAssist Brand of OTC Rechargeable Hearing Aids on Walgreens.com • INND • Apr 5, 2024 8:00 AM. … WebThe COVISTIX™ COVID-19 Virus Rapid Antigen Detection Test is approved under Emergency Use Authorization (EUA) in Mexico by COFEPRIS and in Brazil by ANVISA and cleared for commercialization. Focus Areas Preclinical Clinical Market - Drug (on patent) Market - Generics/OTC WebJul 19, 2024 · Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including Abivertinib, COVISHIELD™ and COVI-MSC™; and diagnostic test solutions, including COVIMARK™. sanga burrough winchester